Promethos Capital, LLC Dr Reddys Laboratories LTD Transaction History
Promethos Capital, LLC
- $264 Billion
- Q2 2024
A detailed history of Promethos Capital, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Promethos Capital, LLC holds 134,734 shares of RDY stock, worth $9.97 Million. This represents 3.87% of its overall portfolio holdings.
Number of Shares
134,734
Previous 117,684
14.49%
Holding current value
$9.97 Million
Previous $8.63 Billion
18.28%
% of portfolio
3.87%
Previous 5.07%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
232Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$153 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$152 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$150 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$148 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$133 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...